Patents Assigned to DRK Blutspendedienst West GmbH
  • Patent number: 9963741
    Abstract: The invention relates to the discovery that HNA-3a and HNA-3b are antigens within a polypeptide sequence that is highly similar to the CTL2 amino acid sequence. This invention provides methods and kits for screening for HNA-3a and HNA-3b specific antibodies, HNA-3a and HNA-3b polypeptides and HNA-3a and HNA-3b nucleic acids in a sample of a biological tissue intended for transplantation.
    Type: Grant
    Filed: April 3, 2015
    Date of Patent: May 8, 2018
    Assignees: ERNST-MORITZ-ARNDT-UNIVERSITÄT GREIFSWALD, DRK BLUTSPENDEDIENST WEST GMBH
    Inventors: Andreas Greinacher, Jan Wesche, Juergen Bux, Angelika Reil
  • Patent number: 8999651
    Abstract: The invention relates to the discovery that HNA-3a and HNA-3b are antigens within a polypeptide sequence that is highly similar to the CTL2 amino acid sequence. This invention provides methods and kits for screening for HNA-3a and HNA-3b specific antibodies, HNA-3a and HNA-3b polypeptides and HNA-3a and HNA-3b nucleic acids in a sample of a biological tissue intended for transplantation.
    Type: Grant
    Filed: March 18, 2013
    Date of Patent: April 7, 2015
    Assignees: Ernst-Moritz-Arndt-Universität Greifswald, DRK Blutspendedienst West GmbH
    Inventors: Andreas Greinacher, Jan Wesche, Juergen Bux, Angelika Reil
  • Publication number: 20130189696
    Abstract: The invention relates to the discovery that HNA-3a and HNA-3b are antigens within a polypeptide sequence that is highly similar to the CTL2 amino acid sequence.
    Type: Application
    Filed: March 18, 2013
    Publication date: July 25, 2013
    Applicants: DRK BLUTSPENDEDIENST WEST GMBH, ERNST-MORITZ-ARNDT-UNIVERSITAT GREIFSWALD
    Inventors: Andreas Greinacher, Jan Wesche, Juergen Bux, Angelika Reil
  • Patent number: 8435733
    Abstract: The invention relates to the discovery that HNA-3a and HNA-3b are antigens within a polypeptide sequence that is highly similar to the CTL2 amino acid sequence. This invention provides methods and kits for screening for HNA-3a and HNA-3b specific antibodies, HNA-3a and HNA-3b polypeptides and HNA-3a and HNA-3b nucleic acids in a sample of a biological tissue intended for transplantation.
    Type: Grant
    Filed: November 29, 2011
    Date of Patent: May 7, 2013
    Assignees: Ernst-Moritz-Arndt-Universität Greifswald, DRK Blutspendedienst West GmbH
    Inventors: Andreas Greinacher, Jan Wesche, Juergen Bux, Angelika Reil
  • Patent number: 8084216
    Abstract: The invention relates to the discovery that HNA-3a and HNA-3b are antigens within a polypeptide sequence that is highly similar to the CTL2 amino acid sequence. This invention provides methods and kits for screening for HNA-3a and HNA-3b specific antibodies, HNA-3a and HNA-3b polypeptides and HNA-3a and HNA-3b nucleic acids in a sample of a biological tissue intended for transplantation.
    Type: Grant
    Filed: September 3, 2009
    Date of Patent: December 27, 2011
    Assignees: Ernst-Moritz-Arndt-Universität Greifswald, DRK Blutspendedienst West GmbH
    Inventors: Andreas Greinacher, Jan Wesche, Juergen Bux, Angelika Reil
  • Publication number: 20100055706
    Abstract: The invention relates to the discovery that HNA-3a and HNA-3b are antigens within a polypeptide sequence that is highly similar to the CTL2 amino acid sequence.
    Type: Application
    Filed: September 3, 2009
    Publication date: March 4, 2010
    Applicants: ERNST-MORITZ-ARNDT-UNIVERSITAT GREIFSWALD, DRK BLUTSPENDEDIENST WEST GMBH
    Inventors: Andreas Greinacher, Jan Wesche, Juergen Bux, Angelika Reil